Avatar
Healthcare_medical

0 Following 0 Followers
2
Adhesion for Health: A Deep Dive into Transdermal Patches Market
The global transdermal patches market is projected to reach 8.0 USD billion by 2029 from USD 6.2 billion in 2023, at a CAGR of 4.5% from 2023 to 2029. The increasing prevalence of chronic diseases, growing adoption of analgesic patches, technological advancements in a transdermal patches, and switching from conventional injections to transdermal patches are all factors driving the growth of the global transdermal patches market. However, throughout the projected period, factors including the drug failure and recalls of transdermal drug delivery systems and the rising cost of healthcare facili
5
Patient Experience Technology Market worth $299 million by 2026
The report "Patient Experience Technology Market by Component (Technology (Patient Rounding, Patient experience survey), Consulting Services) & Facility Type (Acute Care, Post Acute Care, Non Acute Care (Physicians Office, Clinics)) - US Forecasts to 2026", is projected to reach USD 299 million by 2026 from USD 179 million in 2021, at a CAGR of 10.7% during the forecast period of 2021-2026
3
Airway Management Devices Market worth $2.5 billion by 2026
The report "Airway Management Devices Market by type (Endotracheal tubes, Tracheostomy tube, LMA, Oropharyngeal, Nasopharyngeal, Laryngoscopes, Bougies), Application (Anesthesia, Emergency medicine), End user (Hospitals), COVID-19 Impact - Global Forecast to 2026" The airway management devices market is projected to reach USD 2.5 billion by 2026 from USD 1.9 billion in 2021, at a CAGR of 5.8% during the forecast period. Increasing prevalence of chronic respiratory diseases and respiratory tract infections have surged the demand for airway rescue among affected patients. As a result, the airwa
3
Rising Incidence of Rare Diseases Drives Demand for Newborn Screening Tests
The global newborn screening market size is projected to reach USD 1.3 billion by 2026 from USD 0.9 billion in 2021, at a CAGR of 8.3% during the forecast period. Market growth is driven mainly by the increasing prevalence of newborn diseases, government newborn screening programs and legislations, and availability of insurance for newborn screening.